Taiwan
Leadgene Biomedical, Inc., founded in 2013 and headquartered in Taiwan, positions itself at the forefront of the biotechnology sector. The company specializes in immunotechnology, with a focus on antigen prediction, monoclonal antibody development, and protein technologies. Their expertise extends to antibody drug and companion diagnostic development, offering solutions both for in vitro diagnostics and academic research.
With the slogan, "Details Make Our Profession," Leadgene emphasizes the importance of precision and quality in delivering products and services. The company seeks to bridge the gap between upstream and downstream industry players through comprehensive R&D collaborations.
Recently, Leadgene Biomedical, Inc. received funding from Darwin Venture Management as part of a Funding Round on 01 November 2023, which underscores investor confidence in their growth potential. The company is also tapping into the burgeoning Clean Energy industry, showcasing versatility and adaptability in its business ventures.
